If phosphate remains elevated or the patient cannot tolerate calcium-based binders due to constipation or hypercalcemia, which phosphate binder is appropriate?

If phosphate remains elevated or the patient cannot tolerate calcium-based binders due to constipation or hypercalcemia, which phosphate binder is appropriate?

• A. Aluminum hydroxide
• B. Sevelamer
• C. Calcium carbonate
• D. Magnesium oxide

Answer: (B)

Managing high phosphate in CKD relies on binders that act in the gut to prevent phosphate absorption, without adding extra calcium or aluminum. When phosphate remains elevated or calcium-based binders cause constipation or hypercalcemia, a non-calcium binder is preferred. Sevelamer fits this role: it binds dietary phosphate in the intestinal lumen and is excreted in feces, lowering phosphate without raising serum calcium. Aluminum-containing binders can lead to aluminum toxicity with long-term use, and magnesium-based binders risk hypermagnesemia in CKD. Calcium carbonate raises calcium levels and can worsen constipation and hypercalcemia, so it’s avoided in this scenario.

Managing high phosphate in CKD relies on binders that act in the gut to prevent phosphate absorption, without adding extra calcium or aluminum. When phosphate remains elevated or calcium-based binders cause constipation or hypercalcemia, a non-calcium binder is preferred. Sevelamer fits this role: it binds dietary phosphate in the intestinal lumen and is excreted in feces, lowering phosphate without raising serum calcium. Aluminum-containing binders can lead to aluminum toxicity with long-term use, and magnesium-based binders risk hypermagnesemia in CKD. Calcium carbonate raises calcium levels and can worsen constipation and hypercalcemia, so it’s avoided in this scenario.